Cramer's 'Mad Money' Recap: How to Play the Surprising Jobs Report (Update 3)
Cramer says an improving economy means stocks will be heading higher.
06:39PM 12/04/09
Biotech Calendar: Key Dates for December
A calendar of important, potentially stock-moving biotech events for December.
09:56AM 11/30/09
Biotech Stock Mailbag: Targacept
Targacept's depression drug TC-5214 makes it a great candidate to land a lucrative partnership from Big Pharma.
06:00AM 11/27/09
Jim Cramer's Portfolios of the Week
Here's what Cramer's been talking about lately.
08:18AM 11/20/09
Cramer's 'Stop Trading!': Bristol-Myers
Jim Cramer discusses Intel, Boeing, Bristol-Myers and more.
03:55PM 11/16/09
Jim Cramer's Portfolios of the Week
Here's what Jim Cramer's had to say lately.
04:14PM 11/06/09
Cramer's 'Mad Money' Follow-Up: Nov. 5
Here's how some of Wednesday's 'Mad Money' stocks fared on Thursday.
04:35PM 11/05/09
San Diego (TheStreet) -- Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Cisco, Tessera and ImmunoGen.
08:06AM 11/05/09
Cramer's 'Mad Money' Recap: The Bears' Negative Script (Final)
Cramer says the bears' pessimistic message has cost investors a fortune in the market. Click for news from Jim Cramer.
06:28PM 11/04/09
Biotech Calendar: Key Dates for November
Your quick-and-dirty guide to key dates and events for biotech investors during November.
07:12AM 11/02/09
Biotech Mailbag: The Reason(s) for This Selloff
Readers asks why the sector is fading and seek insight on Gilead, Oncothyreon, ImmunoGen and more.
07:00AM 10/30/09
Biotech Calendar: Key Upcoming Trials
Your quick-and-dirty guide to upcoming phase III clinical trials.
06:00AM 10/23/09
Morning Playbook: Dividend.com
Better-than-expected jobless claims and positive sales reports from retailers are buoying the market.
09:38AM 10/08/09
Biotech Mailbag: Myriad Pharma
Adam Feuerstein fields questions on Myriad Pharma, Hemispherx, Cell Therapeutics, Gilead and more.
08:51AM 09/25/09
Sector Snap: Analyst Keeps Positive Biotech View
A Morgan Joseph analyst maintains positive outlooks for Amgen, ImmunoGen, and Isis
12:37PM 09/08/09



Connect with TheStreet